Tris Pharma
Janet joined Tris in May 2013 and leads the generic business unit. She brings a diverse background to Tris. Janet spent the first 12 years of her career working across multiple functional areas within GE and PepsiCo divisions in industries spanning consumer durables, financial services, and hospitality. In 1999 she joined Amerisource, eventually heading up the generics group for Amerisource and then AmerisourceBergen. Since then, Janet has held senior management positions with smaller and mid-sized generic pharmaceutical companies. She holds an MBA from the Schulich School of Business at York University and a BA from Western University.
This person is not in any offices
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.